Ana Rogovic in

Ana Rogovic

Questioner · DISC type c
VP International Affiliates DACH & Nordics at Amicus Therapeutics
📍 Munich, Bavaria, Germany

Ana Rogovic serves as the VP of International Affiliates for DACH & Nordics and Managing Director for Amicus Therapeutics in Germany. Her career is marked by leadership roles in specialized pharmaceuticals at Amgen and Bristol-Myers Squibb. She holds masters degrees in Political Science and International Relations.

She is a passionate advocate for patients with rare diseases, frequently engaging in awareness campaigns. Her public statements emphasize the need for equity in healthcare, better access to therapies, and reducing the daily burden on patients and their families, reflecting a deep commitment to the community her company serves.

Ana represents her company in federal health committee hearings, directly advocating for patient access to new and innovative treatments for rare conditions.

Read the full overview →
Experience
16 Years
Current Role
VP International Affiliates DACH & Nordics
Job Level
Senior
Location
Munich, Bavaria, Germany
Personality Overview

How Ana shows up

Cautious & Analytical
Value Seeker
Price-Sensitive

While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They are more likely than others to negotiate on pricing and terms. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point.

Priorities

Topics Ana cares about

Rare Disease Advocacy
Actively raises awareness for the rare disease community through social media and represents Amicus in health policy discussions, focusing on conditions like Fabry disease.
Patient-Centric Therapies
Champions treatments that reduce patient burden, such as the advantages of oral therapies over infusions, to improve the quality of life for patients and their families.
+4 more topics Login to view topics
Career

Work history

7-2024
VP International Affiliates DACH & Nordics
Amicus Therapeutics
1-2024 - 7-2024
VP International Affiliates DACH
Amicus Therapeutics
1-2022 - 1-2024
Executive Director DACH
Amicus Therapeutics
7-2017 - 1-2020
Business Unit Director Cardiology & Nephrology
Amgen
10-2015 - 6-2017
Business Unit Head General Medicine
Amgen
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1998 - 1998
Mag.phil
Universität Wien
1993 - 1997
Master of Arts (MA)
Webster University (AT)
Social presence
in
Behavioral profile

DISC profile (public)

c

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Ana. Free, 10 seconds.